21 results on '"Gallwitz, B"'
Search Results
2. Rezeptoragonisten des „glucagon-like peptide 1”
3. Neue antihyperglykämische Therapeutika
4. Inkretinbasierte Therapien
5. Gemeinsamkeiten und Unterschiede inkretinbasierter Therapien
6. Neue Ansätze in der Therapie des Typ-2-Diabetes
7. A common genetic variant in WFS1 determines impaired glucagon-like peptide-1-induced insulin secretion
8. The risk allele load accelerates the age-dependent decline in beta cell function
9. Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms
10. Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms
11. Symptomatic hypoglycemia during imatinib mesylate in a non-diabetic female patient with gastrointestinal stromal tumor
12. Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms
13. Neue Substanzen in der oralen Medikation des Diabetes mellitus Typ 2
14. Acromegaly and end-stage renal disease: A diagnostic challenge
15. Behandlungspfade in der Endokrinologie und Diabetologie
16. Paraadrenal Castleman disease presenting with adrenal hyperandrogenism
17. Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans
18. Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes
19. Diabetes mellitus Typ�2
20. Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia
21. Insulinanaloga und neue Antidiabetika
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.